Merck stock starts 2026 higher as Cidara tender-offer deadline hits next week
NEW YORK, Jan 3, 2026, 15:08 ET — Market closed Merck & Co. (MRK) shares ended Friday up about 1.2% at $106.45. Nasdaq said the cash tender offer for Cidara Therapeutics is scheduled to expire one minute after 11:59 p.m. ET on Jan. 6, with the merger tentatively slated to close before the market opens Jan. 7. The exchange said…